Oxidative stress and neuroprotection /
| Other Authors: | , |
|---|---|
| Format: | Book |
| Language: | English |
| Published: |
New York :
Springer,
[2006]
|
| Series: | Journal of neural transmission ;
suppl. 71 |
| Subjects: |
Table of Contents:
- Levodopa in the treatment of Parkinson's disease
- Changing dopamine agonist treatment in Parkinson's disease : experiences with switching to pramipexole
- The DONPAD-study - treatment of dementia in patients with Parkinson's disease with donepzil
- PD-related psychosis : pathophysiology with therapeutical strategies
- Antioxidant capacity in postmortem brain tissues of Parkinson's and Alzheimer's disease
- Apoptosis inhibition in T cells triggers the expression of proinflammatory cytokines - implications for the CNS
- Molecular mechnaism of the relation of monoamine oxidase B and its inhibitors to Parkinson's disease : possible implications of glial cells
- Involvement of type A monoamine oxidase in neurodegeneration : regulation of mitochondrial signaling leading to cell death or neuroprotection
- The relationship of early studies of monoamines oxidase to present concepts
- Isatin, an endogenous MAO inhibitor, and a rat model of Parkinson's disease induced by the Japanese encephalitis virus
- Isatin interation with glyceraldehyde-3-phosphate dehydrogenase, a putative target of neuroprotective drugs : partial agnoism with deprenyl
- Inhibition of amine oxidases by the histamine-1 receptor antagnoist hydroxyzine
- Neuroprotection for Parkinson's disease
- Marker for a preclinical diagnosis of Parkinson's disease as a basis for neuroprotection
- Assessing neuroprotection in Parkinson's disease : from the animal models to molecular neuroimaging in vivo
- Deprenyl : from chemical synthesis to neuroprotection
- The use of rasagiline in Parkinson's disease
- Novel neuroprotective neurotrophic NAP analogs targeting metal toxicity and oxidative stress : potential candidates for the control of neurodegenerative diseases
- Acute and chronic effects of developmental iron deficiency on mRNA expression patterns in the brain
- Long lasting effects on infancy iron deficiency - preliminary results
- Altered regulation of iron transport and storage in Parkinson's disease
- Iron dyshomeostasis in Parkinson's disease
- Cerebral oligemia and iron influence in cerebral structures - element of Morbus Parkinson models
- Impact of selenium, iron, copper and zinc in on/off Parkinson's patients on L-dopa therapy
- Metal specificity of an iron-responsive element in Alzheimer's APP mRNA 5'untranslated region, tolerance of SH-SY5Y and H4 neural cells to desferrioxamine, clioquinol, VK-28, and a pierazine chelator
- Green tea catechins as brain-permeable, non toxic iron chelators to "iron out iron" from the brain